Evidence map›Paper›PMID 41273741›Full record

ArticleMedicina oral, patologia oral y cirugia bucal2026

Clinical study on hemorrhagic complications in antiplatelet and anticoagulated patients undergoing dental treatment.

C López-Carriches, R Taheri, C Madrigal-Martínez-Pereda

Abstract read
In one paragraph

Article in Medicina oral, patologia oral y cirugia bucal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

C López-CarrichesUniversidad Complutense of Madrid Plaza Ramón y Cajal, s/n. 28040 Madrid, Spain maclopez@ucm.es.
R Taheri
C Madrigal-Martínez-Pereda

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients undergoing treatment with antiplatelet or anticoagulant drugs are attending dental consultations. Therefore, it has become essential to evaluate the patient before treatment and to conduct a thorough medical history. The goal of this study is to analyze the patients attending a dental clinic over a period of 6 months to determine how many are taking antiplatelet or anticoagulant medications, what dental treatment they seek, what hemostatic measures are taken, and whether they suffer hemorrhagic complications as a result of the treatment. This will help to prevent such complications by applying appropriate protocols, especially in the field of oral surgery. MATERIAL AND

methodsOver a six-month period, 867 patients attended a dental clinic in Madrid. Of these, 43 were taking antiplatelet agents or anticoagulants. A descriptive statistical analysis was conducted to gather data on age, gender, medication, dental treatment received, and hemorrhagic complications.

resultsOnly 4.9% of the patients attending the dental clinic were taking antiplatelet or anticoagulant medications. Specifically, 53.48% were taking antiplatelet agents, 34.8% were taking direct oral anticoagulants, and 11.62% were on vitamin K antagonist anticoagulants. After applying the appropriate clinical protocol in each case, only one patient experienced postoperative bleeding, which was not severe.

conclusionsBased on the results, it may not be necessary to withdraw antiplatelet or anticoagulant therapy due to the low incidence and non-severity of complications in simple dental procedures.

Indexed as

AnticoagulantsDental CareHemorrhageOral HemorrhagePlatelet Aggregation InhibitorsPostoperative HemorrhageAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedYoung AdultAnticoagulantsPlatelet Aggregation Inhibitors

Identifiers

PMID41273741
PMCPMC12983381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.